Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative 
disorders, which share a common denominator of overall poor prognosis, with few 
exceptions. In this article, the authors review current standard of care 
approaches for the treatment of PTCLs, the role of stem-cell/bone marrow 
transplantation, and current developments in novel targeted therapies.